Does HLADQA1*05 carrier status impact real-🌎 aTNF outcomes? Maybe not so much @FineMDisso
▶️ 53% carrier rate
▶️ Similar rate of aTNF continuation (>80%)
▶️ No diff in clinically significant anti-drug Ab with only 13% carriers on concurrent IMM
https://t.co/bryHuWoDQl
Excited to share our work on “Real-World Experience Of The Association of HLADQA1*05 Allele with Loss of Response to Anti-TNF Inhibitors”
Check out our manuscript here 👉 https://t.co/8rAscrU5ww
@FineMDisso@IBDJournals
MyIBD Learning: Boston Patient & Caregiver Conference is coming up on May 4! Don’t miss this day of IBD education, connection & community. Register now: https://t.co/3huOvLH1ml
Apply now to our 2024-2025 Visiting IBD Fellowship! https://t.co/iUiUG5ayq9 This clinical observership offers GI fellows the opportunity to accelerate their career development and gain practical experience by participating in the clinical operations of a leading IBD center.
Predictors of disease activity during pregnancy in wen with IBD include:
-disease activity within 6 months prior to conception
- disease activity in previous pregnancy
-ulcerative colitis
An important topic
IBD and pregnancy
Will aspirin lead to a flare if being used to prevent pre-eclampsia?
✅@UmaMahadevanIBD teaching the audience that patients with IBD are at ⬆️risk for pre-eclampsia andLow dose aspirin 💊 is safe/recommended to use in patients
Excellent Med/Surgery discussion going on right now at #AIBD2023 with patient advocate @ownyourcrohns@MRegueiroMD
✅in depth discussions
✅use diagrams to help explain terminology to our patients
✅communication about plans after surgery if treatment may still
Be needed